New UC Riverside-led research suggests Alzheimer’s arises not simply from plaques forming in the brain, as is widely believed ...
The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the levels of two ...
A new study has revealed that Alzheimer's disease breaks apart nerves and blood vessels in fat tissue throughout the body. The finding could help explain the disease's ravages beyond mental impairment ...
A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...
Morning Overview on MSN
Hidden brain glitch may explain why Alzheimer’s risk soars with age
A single-letter change in a protein that guards brain cells against a toxic form of death may help explain why Alzheimer’s disease strikes so aggressively in older adults. A missense variant in the ...
Hosted on MSN
The Most Devastating Symptom Of Alzheimer's Finally Has An Explanation – And, Maybe Soon, A Treatment
One of the most famous symptoms of Alzheimer's – and definitely one of the most devastating – is when patients start to forget their friends, family, and loved ones. Thanks to a new study from ...
For decades, researchers have noted that cancer and Alzheimer’s disease are rarely found in the same person, fuelling speculation that one condition might offer some degree of protection from the ...
For many years, experts believed that this gap existed mainly because women live longer. While age is still a major risk factor, newer research suggests that longevity does not fully explain why women ...
Alzheimer’s may be driven far more by genetics than previously thought, with one gene playing an outsized role. Researchers found that up to nine in ten cases could be linked to the APOE gene — even ...
Researchers found that white matter lesions linked to Alzheimer’s do not always worsen, but can shrink during disease ...
A Massachusetts woman with early onset Alzheimer's fought her insurer over a denied treatment, raising questions about age ...
Anavex’s precision medicine approach recognizes that Alzheimer’s pathology is heterogeneous, but autophagy dysfunction represents a causative co-factor that precedes divergent downstream ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results